Around 90 percent of the drugs for Covid sufferers in intensive care units are generics – that is, copycat drugs with the same active ingredients but usually cheaper after the patent protection of the original preparation has expired. The most frequently used groups of substances are analgesics, antibiotics, anesthetics, cardiac therapeutics and gastric protection drugs. The Generikaverband (OeGV) pointed this out on Thursday in an online press conference based on data from Germany, among other things.
Almost exclusively generics
“Generics play an essential role in the treatment of Covid-19 sufferers who need intensive care,” said OeGV President Wolfgang Andiel. Analgesics (99 percent generic share), antibiotics (85 percent) and anesthetics (95 percent) are almost exclusively prescribed as generic drugs. The contribution of the European generics industry to coping with the corona crisis is enormous. Especially at the beginning of the pandemic, when the situation in Lombardy, for example, worsened, classic intensive care drugs became scarce.
No supply bottlenecks
“Thanks to the cooperation with the European institutions and across company and industry boundaries, it has been possible to keep the drugs available despite unprecedented pressure and to prevent major supply disruptions,” Andiel emphasized. The demand situation currently looks different again, but the political focus on security of supply has not disappeared. “It is clear that promoting more domestic or European production should be part of the overall strategy. At the same time, however, we need more than one tool in our toolbox – and we must avoid the risk of recreating the same problem of supply dependency elsewhere.” said the OeGV President.